Skip to main content

Texas Medical Center’s Innovation Branch has welcomed seven companies into its 2022 Health Technology Accelerator Program Acceleration Program.

TMC Innovation Accelerator for HealthTech aims to support early-stage life science startups through fundraising, connecting with mentors and potential customers, and more.

“Healthtech startups that connect to our network will emerge more prepared to access their customers and grow in their markets,” Emily Reiser, associate director of TMC Innovation, said in a press release. “Our advisors, members, and partners unlock insights for these entrepreneurs on how to more effectively build a strategic plan to improve market access and adoption. Bootcamp ignites these connections, delivering immediate value to entrepreneurs and empowering our team to define a long-term plan for continued collaboration.”

If selected after the bootcamp, Founders will spend six months at TMCi with strategic mentorship, clinical validation, and other personalized development stages of the organization.

“Bootcamp is an intensive period of discovery and mutual selection,” Devin Dunn, Accelerator Manager for HealthTech, said in the release. “Founders have a chance to better understand all that TMCi brings and our team has the opportunity to select those growing businesses that will add significant value to our community.

The bootcamp focused on several areas of innovation, including surgical devices, access to care, robotics and hospital efficiency. Participating companies include:

  • CardMedic, headquartered in Oxford, UK, aims to improve communication between staff and patients, regardless of language, deafness, cognitive impairment or disability, with an A-Z library pre-written scripts reproducing common clinical conversations.
  • Chicago-based CareAdvisors connects health plans, hospitals and community organizations to streamline management of high-risk cases and quickly close the loop of care.
  • Endolumik, founded in Morgantown, West Virginia, has developed a fluorescence-guided device that uses near-infrared light to improve visualization for safer, faster, and more consistent bariatric surgery.
  • Orcha, based in Daresbury, UK, rigorously reviews apps to help systems, clinicians, patients or consumers find the best health-related apps.
  • Austin-based Roboligent has created a rehabilitation robot, the Optimo Regen, which provides evidence-based therapeutic interventions for upper and lower limbs.
  • The Boston-founded ScienceIO platform transforms unstructured text into structured records in real time. The company’s core product is a HIPAA-compliant API for real-time text processing and analysis.
  • Semantic Health, founded in Toronto, Canada, uses artificial intelligence to perform secondary reviews of all coded data and claims to optimize revenue cycle management.
The application for future cohorts and more information about the program are available online. The 2022 cohort will join the ranks of the TMCi community of 305 life science startups and 221 TMC Innovation Accelerator companies and gain access to the center’s dozens of member organizations.

“Having a product that the market really needs is essential but not sufficient,” Bongsu Kim, founder and CEO of Roboligent, said in the statement. “Particularly for the medical device market, I realize that introducing a new product is a thorough and collaborative effort of a variety of stakeholders and experts. Without knowing the mechanism and the right connection, it seems almost impossible to enter the market. The TMC The Innovation Accelerator is the perfect place to make it happen.”